Crossmark

Willingness to Use Oral and Long-Acting Injectable PrEP in Substance-Using Men who have Sex with Men (SU-MSM) in High HIV Incidence Southern U.S. Cities: A NIDA Clinical Trials Network Study

Crossref DOI link: https://doi.org/10.1007/s10461-024-04594-7

Published Online: 2024-12-30

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tross, Susan

Laschober, Tanja C.

Paschen-Wolff, Margaret

Ertl, Melissa

Nelson, C. Mindy

Wright, Lynette

Lancaster, Chloe

Feaster, Daniel J.

Monger, Mauda

Toal, Phil

Fegley, Joshua P.

Meche, David

Hankey, Colby

Woodhouse, Christina

Spector, Anya

Dresser, Lauren

Moran, Landhing

Jelstrom, Eve

Haynes, Louise

Shoptaw, Steven

Hatch, Mary A.
Funding

Funding for this research was provided by:

NIH (UG1DA013035, UG1DA013714, HHSN271201400028C, T32 MH019139, P30-MH43520)

NIDA (75N95020D00012)

National Institute of Diabetes and Digestive and Kidney Diseases (R25 DA050687-01A1)
License Information

Text and Data Mining valid from 2024-12-30

Version of Record valid from 2024-12-30
More Information

Article History

Accepted: 18 December 2024

First Online: 30 December 2024

Declarations

:

: The University of Washington Human Subjects Division determined that this study (STUDY00007617) was exempt from federal human subjects regulations, including the requirement for a full IRB review approval and continuing review.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below